EMBL Australia

News this quarter:

• EMBL Australia secures $2 million for AusRISE program
• Australia welcomes its first EMBL ARISE Fellow at Monash Uni
• Building project management skills across career stages
• We welcome move to accelerate Horizon Europe association
• Monash Bioinformatics manager gains global insights at EMBL‑EBI leadership workshop
• ARISE2: Advance your research infrastructure career at EMBL

And more:

• Job opportunities
• Training at EMBL
• Upcoming events
• Recent publications

EMBL Australia welcomes new funding through the Australian Government’s NCRIS, supporting its infrastructure research fellowship program and strengthening workforce development across the life sciences.

Early‑career researchers from across the EMBL Australia community recently took part in tailored project management training delivered by EMBL’s International Centre for Advanced Training.

The fast‑tracking of the Australian Government’s Horizon Europe negotiations signals a major shift toward deeper global research collaboration and expanded opportunities for Australian scientists.

Dr Laura Perlaza‑Jiménez joined bioinformatics leaders from around the world to take part in a unique course on managing a bioinformatics core facility at the European Bioinformatics Institute.

Australia is set to welcome its first fellow from the European Molecular Biology Laboratory’s ARISE programme as Monash University joins the global research infrastructure training network.

News this quarter:

• EMBL Australia PhD Course celebrates 10 years of training our future research leaders
• New research offers hope for better malaria treatment
• Partner Laboratory Network celebrates multiple grant wins
• Eduardo Eyras appointed Director of Shine‑Dalgarno Centre for RNA Innovation
• A new era for Australia-Europe life science partnerships
• Prof Jose Polo elected as a 2025 new Fellow of the AAHMS
• Honouring the legacy of the late Professor Peer Bork

And more:

• Job opportunities
• Student opportunities
• Training at EMBL
• Recent publications

 

A study led by EMBL Australia Group Leader Dr Michelle Boyle has uncovered a potential breakthrough in malaria treatment using anti-inflammatory drug ruxolitinib to both reduce harmful inflammation and boost immune protection against malaria.

EMBL Australia group leader Professor Eduardo Eyras has been appointed as Director of the Shine‑Dalgarno Centre for RNA Innovation.

EMBL Australia researchers and alumni have been awarded more than $7 million in recent grant funding, enabling ambitious new research projects that push the boundaries of fundamental science across our network.